BackAstraZeneca PLC Overview

AstraZeneca PLC Receivables

Track AstraZeneca PLC's receivables ($16B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$16.35B
↑ 14.03% YoYΔ $2.01B vs prior year quarter

Peer trimmed avg / median

Loading

AstraZeneca PLC Receivables History

Loading

AstraZeneca PLC vs. peers: Receivables Comparison

Loading

AstraZeneca PLC Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

AstraZeneca PLC (ZEG.DE) FAQ

AstraZeneca PLC (ZEG.DE) currently reports a receivables of $16B as of September 2026. That compares with $14B in the prior-year period — up 14.0% year over year. Use the charts on this page to explore AstraZeneca PLC's receivables history and peer comparisons.

AstraZeneca PLC's receivables increased from $14B to $16B — a 14.0% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AstraZeneca PLC reported $16B in receivables as of September 2026. That compares with $14B in the prior-year period — up 14.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $16B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AstraZeneca PLC, and consider following ZEG.DE for alerts when major investors trade the stock.

AstraZeneca PLC is classified in the Healthcare sector. On receivables, it currently shows $16B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ZEG.DE with unrelated industries.